Wird geladen...

Targeting survivin and p53 in pediatric acute lymphoblastic leukemia

Despite advances in treatment and outcomes for patients with pediatric acute lymphoblastic leukemia (ALL), there continue to be subsets of patients who are refractory to standard chemotherapy and hematopoietic stem cell transplant. Therefore, novel gene targets for therapy are needed to further adva...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tyner, J W, Jemal, A M, Thayer, M, Druker, B J, Chang, B H
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group 2012
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3364442/
https://ncbi.nlm.nih.gov/pubmed/21960246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2011.249
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!